Dr. Scott Borinstein, M.D.
Claim this profileVanderbilt University/Ingram Cancer Center
Expert in Cancer
Expert in Osteosarcoma
32 reported clinical trials
53 drugs studied
Area of expertise
1Cancer
Global LeaderStage I
Stage IV
Stage II
2Osteosarcoma
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Scott Borinstein, M.D. is currently running
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Nivolumab + Chemotherapy
for Nasopharyngeal Cancer
This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Researchers want to find out what effects, good and/or bad, adding nivolumab to chemotherapy has on patients with newly diagnosed NPC. In addition, they want to find out if children with NPC may be treated with less radiation therapy and whether this decreases the side effects of therapy.
Recruiting1 award Phase 25 criteria
More about Scott Borinstein, M.D.
Clinical Trial Related8 years of experience running clinical trials · Led 32 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Scott Borinstein, M.D. has experience with
- Cyclophosphamide
- Cisplatin
- Vincristine
- Dactinomycin
- Vinorelbine
- Gemcitabine
Breakdown of trials Scott Borinstein, M.D. has run
Cancer
Osteosarcoma
Soft Tissue Sarcoma
Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Borinstein, M.D. specialize in?
Scott Borinstein, M.D. focuses on Cancer and Osteosarcoma. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage IV.
Is Scott Borinstein, M.D. currently recruiting for clinical trials?
Yes, Scott Borinstein, M.D. is currently recruiting for 7 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Scott Borinstein, M.D. has studied deeply?
Yes, Scott Borinstein, M.D. has studied treatments such as Cyclophosphamide, Cisplatin, Vincristine.
What is the best way to schedule an appointment with Scott Borinstein, M.D.?
Apply for one of the trials that Scott Borinstein, M.D. is conducting.
What is the office address of Scott Borinstein, M.D.?
The office of Scott Borinstein, M.D. is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.